Service de Prévention du Risque Infectieux (LESPRI), CLIN AP-HM Hôpitaux Universitaires de Marseille, Marseille, France.
Microbes, Evolution, Phylogeny and Infections (MEPHI), AP-HM, Aix-Marseille Université, Marseille, France; IHU Méditerranée Infection, Marseille, France.
J Hosp Infect. 2024 Oct;152:21-27. doi: 10.1016/j.jhin.2024.07.009. Epub 2024 Jul 31.
Necrotizing enterocolitis is the most severe life-threatening acquired gastrointestinal disorder among preterm neonates. We describe here an outbreak of Clostridium butyricum-related necrotizing enterocolitis in preterm neonates that occurred in three different neonatal centres, in southeast France.
We defined a confirmed case of C. butyricum-related necrotizing enterocolitis in preterm neonates by the presence of clinical signs according to modified Bell criteria and C. butyricum identified from stool samples using real-time polymerase chain reaction or culture. A phylogenetic analysis of the isolated strains by whole-genome sequencing was also performed.
Between 5 and 27 January 2022, we identified 10 confirmed cases of C. butyricum-related necrotizing enterocolitis, including five from Neonatal Centre 1, four from Neonatal Centre 2, and one from Neonatal Centre 3. The attack rate of necrotizing enterocolitis in Neonatal Centre 1 was 7.1% (5/70). The positivity rate of C. butyricum detected from stool samples was higher during the outbreak period (37/276; 13.4%) than outside this period (7/369; 1.9%), while systematic screening was maintained (P<0.001). Phylogenetic analysis showed a clonality between strains inside four clusters. Two clusters included neonates hospitalized in different neonatal centres, suggesting the transmission of C. butyricum strains during the transfer of neonates between neonatal centres.
This outbreak of C. butyricum-related necrotizing enterocolitis confirms a cross-transmission between preterm neonates, including twin or triplet siblings, and involving necrotizing enterocolitis cases together with asymptomatic carriers. After three months of follow-up, no further cases were identified following the implementation of contact precautions with sporicidal agents.
坏死性小肠结肠炎是早产儿最严重的危及生命的获得性胃肠道疾病。我们在此描述了法国东南部三个不同新生儿中心发生的与丁酸梭菌相关的坏死性小肠结肠炎暴发。
我们通过改良的 Bell 标准确定了早产儿中存在临床症状的丁酸梭菌相关坏死性小肠结肠炎确诊病例,并通过实时聚合酶链反应或培养从粪便样本中鉴定出丁酸梭菌。还对分离株进行了全基因组测序的系统发育分析。
在 2022 年 1 月 5 日至 27 日期间,我们确定了 10 例丁酸梭菌相关坏死性小肠结肠炎确诊病例,其中 5 例来自新生儿中心 1,4 例来自新生儿中心 2,1 例来自新生儿中心 3。新生儿中心 1 的坏死性小肠结肠炎发病率为 7.1%(5/70)。暴发期间从粪便样本中检测到的丁酸梭菌阳性率(37/276;13.4%)高于非暴发期间(7/369;1.9%),但系统筛查仍在继续(P<0.001)。系统发育分析显示四个聚类中菌株之间存在克隆性。两个聚类包括在不同新生儿中心住院的新生儿,这表明在新生儿中心之间转移期间丁酸梭菌菌株的传播。
此次丁酸梭菌相关坏死性小肠结肠炎暴发证实了早产儿之间的交叉传播,包括双胞胎或三胞胎兄弟姐妹,并涉及坏死性小肠结肠炎病例和无症状携带者。在实施接触预防措施并使用杀孢子剂三个月后,没有发现进一步的病例。